General Information of the Compound
Compound ID
CP0548230
Compound Name
1-(3-chlorophenyl)sulfonyl-4-piperazin-1-ylimidazo[4,5-c]pyridine
    Show/Hide
Formula
C16H16ClN5O2S
Molecular Weight
377.857
Canonical SMILES
Clc1cccc(c1)S(=O)(=O)n1cnc2c(nccc12)N1CCNCC1
    Show/Hide
InChI
InChI=1S/C16H16ClN5O2S/c17-12-2-1-3-13(10-12)25(23,24)22-11-20-15-14(22)4-5-19-16(15)21-8-6-18-7-9-21/h1-5,10-11,18H,6-9H2
    Show/Hide
InChIKey
MMZBVOVVPMVDQY-UHFFFAOYSA-N
Physicochemical Property
logP
1.7313
Rotatable Bonds
3
Heavy Atom Count
25
Polar Areas
80.12
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
7
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
ChEMBL ID
CHEMBL4777550
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000094 1321N1 Homo sapiens (Human)  1
1
IC50 = 6.6 nM
   TI
   LI
   LO
   TS